ID | Author | Year | Methods | Subjects | Interventions | Scales | |
Diagnosis | Sample size (n) | ||||||
1 | Roman et al26 | 2018 | Randomised double blind | Fibromyalgia | 31 | Three probiotic mixtures or above | STAI |
2 | Farhangi et al21 | 2018 | Randomised triple blind | T2DM* | 62 | Resistant dextrin† | GHQ, DASS |
3 | Schumann et al22 | 2018 | Randomised single blind | IBS | 59 | Low FODMAP | HADS |
4 | Sawada et al17‡ | 2017 | Randomised double blind | Healthy individuals§ | 24 | Lactobacillus gasseri | HADS,STAI |
5 | Sanchez et al23 | 2017 | Randomised double blind | Obesity | 105 | Lactobacillus rhamnosus | STAI |
6 | Romijn et al27 | 2017 | Randomised double blind | IBS | 79 | Two probiotic mixtures† | DASS |
7 | Pinto-Sanchez et al18 | 2017 | Randomised double blind | IBS | 44 | Bifidobacterium longum | HADS,STAI |
8 | Kelly et al20‡ | 2017 | Randomised | Healthy individuals§ | 29 | L. rhamnosus | BAI, STAI |
9 | Eswaran et al28 | 2017 | Randomised single blind | IBS | 84 | Low FODMAP† | HADS |
10 | Colica et al29 | 2017 | Randomised | Healthy individuals | 30 | At least three probiotic mixtures | HAM-A |
11 | Azpiroz et al30 | 2017 | Randomised double blind | IBS | 79 | scFOS | HADS |
12 | Lyra et al31 | 2016 | Randomised triple blind | IBS | 340 | Lactobacillus acidophilus† | HADS |
13 | Steenbergen et al32 | 2015 | Randomised triple blind | Healthy individuals | 89 | At least three probiotic mixtures | BAI |
14 | Lorenzo-Zúñiga et al33 | 2014 | Randomised triple blind | IBS | 84 | At least three probiotic mixtures | VSI |
15 | Peters et al34‡ | 2014 | Randomised double blind | IBS | 22 | Supplementation of gluten | STPI |
16 | Alipour et al35 | 2014 | Randomised double blind | RA* | 46 | Lactobacillus casei† | STAI |
17 | Yuman and Yingwei36 | 2013 | Randomised double blind | Healthy individuals | 82 | Nutritional interventions | HAM-A |
18 | Messaoudi et al19 | 2011 | Randomised double blind | Healthy individuals | 55 | Two probiotic mixtures | HADS HSCL-90 |
19 | Simrén et al37 | 2010 | Randomised double blind | IBS | 74 | At least three probiotic mixtures | HADS |
20 | Silk et al38‡ | 2009 | Randomised single blind | IBS | 44 | Trans-galactooligosaccharide mixture | HADS |
21 | Rao et al39 | 2009 | Randomised double blind | CFS | 39 | L. casei | BAI |
DASS-42 refers to the 42-item self-report questionnaire designed to assess current severity of symptoms relating to depression, anxiety and stress.
*All the subjects were female.
†Studies conducted treatment as usual (TAU) plus interventions regulating intestinal flora (IRIF) interventions.
‡Cross-over study design.
§All the subjects were male.
BAI, Beck Anxiety Inventory; CFS, chronic fatigue syndrome; DASS-42, Depression, Anxiety and Stress Scale; GHQ, General Health Questionnaire; HADS, Hospital Anxiety and Depression Scale; HAM-A, Hamilton Anxiety Rating Scale; HSCL-90, Hopkins Symptom Checklist; IBS, irritable bowel syndrome; RA, rheumatoid arthritis; STAI, State-Trait Anxiety Inventory; STPI, the State Trait Personality Inventory; T2DM, type 2 diabetes mellitus; VSI, Visceral Sensitivity Index; low FODMAP, diet low in fermentable oligosaccharides, disaccharides, and monosaccharides and polyols; scFOS, short-chain fructooligosaccharides.